Intuitive Surgical, Inc. (NASDAQ:ISRG) Holdings Raised by Wahed Invest LLC

Wahed Invest LLC boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 13.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 8,519 shares of the medical equipment provider's stock after acquiring an additional 981 shares during the period. Intuitive Surgical comprises 0.7% of Wahed Invest LLC's portfolio, making the stock its 27th largest holding. Wahed Invest LLC's holdings in Intuitive Surgical were worth $4,185,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently modified their holdings of the business. Massachusetts Financial Services Co. MA acquired a new stake in shares of Intuitive Surgical during the third quarter valued at $558,807,000. International Assets Investment Management LLC boosted its stake in shares of Intuitive Surgical by 49,383.6% during the 3rd quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider's stock worth $535,788,000 after purchasing an additional 1,088,415 shares during the last quarter. FMR LLC grew its holdings in shares of Intuitive Surgical by 8.3% during the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider's stock worth $5,389,765,000 after buying an additional 838,793 shares in the last quarter. Strategic Financial Concepts LLC grew its holdings in shares of Intuitive Surgical by 40,221.4% during the second quarter. Strategic Financial Concepts LLC now owns 266,121 shares of the medical equipment provider's stock worth $1,184,000 after buying an additional 265,461 shares in the last quarter. Finally, State Street Corp raised its position in shares of Intuitive Surgical by 1.4% in the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider's stock valued at $7,393,673,000 after buying an additional 210,363 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.

Analysts Set New Price Targets

Several research firms have commented on ISRG. Stifel Nicolaus lifted their target price on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a "buy" rating in a research note on Thursday. Robert W. Baird lifted their price objective on Intuitive Surgical from $503.00 to $565.00 and gave the company an "outperform" rating in a research report on Thursday, October 17th. Morgan Stanley upgraded Intuitive Surgical from an "equal weight" rating to an "overweight" rating and upped their target price for the company from $522.00 to $650.00 in a research note on Monday. Wells Fargo & Company raised their price target on Intuitive Surgical from $466.00 to $549.00 and gave the stock an "overweight" rating in a research note on Friday, October 18th. Finally, Oppenheimer reaffirmed a "market perform" rating on shares of Intuitive Surgical in a research note on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat.com, Intuitive Surgical has an average rating of "Moderate Buy" and an average price target of $541.33.

Insider Buying and Selling at Intuitive Surgical

In related news, insider Jamie Samath sold 269 shares of the company's stock in a transaction on Monday, November 11th. The shares were sold at an average price of $539.89, for a total value of $145,230.41. Following the sale, the insider now directly owns 8,757 shares of the company's stock, valued at $4,727,816.73. This represents a 2.98 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, SVP Mark Brosius sold 2,128 shares of the firm's stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the transaction, the senior vice president now directly owns 273 shares of the company's stock, valued at approximately $140,595. This represents a 88.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 51,023 shares of company stock valued at $26,384,247 in the last ninety days. Insiders own 0.90% of the company's stock.

Intuitive Surgical Stock Up 0.5 %

Shares of NASDAQ ISRG traded up $2.76 on Friday, hitting $550.41. The company had a trading volume of 1,026,081 shares, compared to its average volume of 1,443,727. The business has a 50 day moving average of $514.78 and a two-hundred day moving average of $472.60. The firm has a market capitalization of $196.04 billion, a P/E ratio of 88.49, a PEG ratio of 5.33 and a beta of 1.38. Intuitive Surgical, Inc. has a 12-month low of $307.72 and a 12-month high of $556.23.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.24 by $0.32. The company had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. On average, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.